 |
|
Heating heart with catheter better than drugs for common heart rhythm disorder
May 15, 2009MAYWOOD, Il. -- Treating a common heart rhythm disorder by burning heart tissue with a catheter works dramatically better than drug treatments, a major international study has found.
One year after undergoing a treatment called catheter ablation, 63 percent of patients with an irregular heartbeat called atrial fibrillation were free of any recurrent atrial arrhythmias or symptoms. By comparison, only 17 percent of those treated with drugs were arrhythmia-free. Results were so convincing the trial was halted early.
The ablation group also scored significantly higher on a quality-of-life scale.
The study included 167 patients at 19 centers, including 15 centers in the United States. Lead researcher Dr. David Wilber presented results at Heart Rhythm 2009, the Society's 30th Annual Scientific Sessions. Wilber is director of the Cardiovascular Institute at Loyola University Stritch School of Medicine in Maywood, Il.
Atrial fibrillation, often called A-Fib, is the most common form of irregular heartbeat. Electrical signals, which regulate the heartbeat, become erratic. Instead of beating regularly, the upper chambers of the heart quiver. Not all the blood gets pumped out, so clots can form. Atrial fibrillation can lead to strokes and heart failure.
A-Fib patient Robin Drabant, 35, of Hanover Park, Il., said the condition once "made me feel like I was 90 years old with a failing heart." She was on a maximum dose of an A-Fib medication, which caused fatigue. Despite the drug, she still had episodes almost every day, lasting from 10 seconds to an hour or longer. "I would lose my breath and could feel my heart racing and fluttering," she said.
Wilber performed a catheter ablation on Drabant in May, 2008, and she no longer has A-Fib episodes. "I had great results," she said.
A-Fib symptoms include heart palpitations, dizziness, fatigue, shortness of breath and fainting. "A lot of people are disabled," Wilber said. "They have no energy. They can't work. They have a very poor quality of life."
More than 2 million Americans have atrial fibrillation, and there are about 160,000 new cases each year. The number is increasing, due in part to the aging population and the obesity epidemic.
Drugs such as beta blockers and calcium channel blockers can slow the heart rate during an A-Fib episode. Other drugs such as flecainide and propafenone can help maintain a normal rhythm. When drugs don't work or produce unacceptable side effects, alternative treatments include a pacemaker, surgery and catheter ablation.
In the ablation procedure, an electrophysiologist destroys small areas of heart tissue that are responsible for the erratic electrical signals. A catheter (thin flexible tube) is guided through blood vessels to the heart. The tip of the catheter delivers radiofrequency energy that heats and destroys tissue. Possible adverse effects include irritation of the lining of the heart, fluid in the lungs or around the heart, bleeding, clots and stroke.
In the study, 106 patients with frequent episodes of atrial fibrillation were randomly assigned to undergo ablation and 61 similar patients were randomly assigned to receive drug therapy. All patients had experienced at least three episodes of atrial fibrillation during the previous six months and had failed at least one attempt to control the rhythm with drugs.
The study was funded by Biosense Webster, which makes the ThermoCool catheter used in the trial. Wilber is a consultant to the company.
The study was the largest to date to compare ablation to drug therapy for atrial fibrillation. Earlier studies involved single centers and smaller sample sizes, Wilber said. An additional study called CABANA is designed to determine whether ablation patients live longer than patients receiving medication. Researchers will follow about 3,000 patients for three years.
Loyola University Health System
The study included 167 patients at 19 centers, including 15 centers in the United States. Lead researcher Dr. David Wilber presented results at Heart Rhythm 2009, the Society's 30th Annual Scientific Sessions. Wilber is director of the Cardiovascular Institute at Loyola University Stritch School of Medicine in Maywood, Il.
Atrial fibrillation, often called A-Fib, is the most common form of irregular heartbeat. Electrical signals, which regulate the heartbeat, become erratic. Instead of beating regularly, the upper chambers of the heart quiver. Not all the blood gets pumped out, so clots can form. Atrial fibrillation can lead to strokes and heart failure.
A-Fib patient Robin Drabant, 35, of Hanover Park, Il., said the condition once "made me feel like I was 90 years old with a failing heart." She was on a maximum dose of an A-Fib medication, which caused fatigue. Despite the drug, she still had episodes almost every day, lasting from 10 seconds to an hour or longer. "I would lose my breath and could feel my heart racing and fluttering," she said.
Wilber performed a catheter ablation on Drabant in May, 2008, and she no longer has A-Fib episodes. "I had great results," she said.
A-Fib symptoms include heart palpitations, dizziness, fatigue, shortness of breath and fainting. "A lot of people are disabled," Wilber said. "They have no energy. They can't work. They have a very poor quality of life."
More than 2 million Americans have atrial fibrillation, and there are about 160,000 new cases each year. The number is increasing, due in part to the aging population and the obesity epidemic.
Drugs such as beta blockers and calcium channel blockers can slow the heart rate during an A-Fib episode. Other drugs such as flecainide and propafenone can help maintain a normal rhythm. When drugs don't work or produce unacceptable side effects, alternative treatments include a pacemaker, surgery and catheter ablation.
In the ablation procedure, an electrophysiologist destroys small areas of heart tissue that are responsible for the erratic electrical signals. A catheter (thin flexible tube) is guided through blood vessels to the heart. The tip of the catheter delivers radiofrequency energy that heats and destroys tissue. Possible adverse effects include irritation of the lining of the heart, fluid in the lungs or around the heart, bleeding, clots and stroke.
In the study, 106 patients with frequent episodes of atrial fibrillation were randomly assigned to undergo ablation and 61 similar patients were randomly assigned to receive drug therapy. All patients had experienced at least three episodes of atrial fibrillation during the previous six months and had failed at least one attempt to control the rhythm with drugs.
The study was funded by Biosense Webster, which makes the ThermoCool catheter used in the trial. Wilber is a consultant to the company.
The study was the largest to date to compare ablation to drug therapy for atrial fibrillation. Earlier studies involved single centers and smaller sample sizes, Wilber said. An additional study called CABANA is designed to determine whether ablation patients live longer than patients receiving medication. Researchers will follow about 3,000 patients for three years.
Loyola University Health System
Atrial Fibrillation Current Events and Atrial Fibrillation News RSSSize matters: Obesity leading risk factor of left atrial enlargement during aging
Aside from aging itself, obesity appears to be the most powerful predictor of left atrial enlargement (LAE), upping one's risk of atrial fibrillation (the most common type of arrhythmia), stroke and death.
Experts unveil new CVD guidelines and position papers
Several new guidelines and position papers offering the most up to date information to ensure that clinicians practice evidence-based medicine were released at the Canadian Cardiovascular Congress 2009 this week.
Learning the risks for stroke - and taking action
With this theme in mind, the European Society of Cardiology (ESC) emphasises that most of the risks for stroke are also the major risks for coronary heart disease - and thus the object of the ESC's far-reaching prevention programme.
Afib triggered by a cell that resembles a pigment-producing skin cell
The source and mechanisms underlying the abnormal heart beats that initiate atrial fibrillation (Afib), the most common type of abnormal heart beat, have not been well determined.
New blood-thinning drug safer than rat poison
In an article reviewed by F1000 Medicine Faculty Members Robert Ruff, Brian Olshansky and Luis Ruilope, the blood-thinner dabigatran is shown to protect against stroke, blood clotting and major bleeding as effectively as warfarin, but with fewer side effects.
Women with diabetes at increased risk for irregular heart rhythm
Diabetes increases by 26 percent the likelihood that women will develop atrial fibrillation (AF), a potentially dangerous irregular heart rhythm that can lead to stroke, heart failure, and chronic fatigue.
Women with Atrial Fibrillation Are at Significantly Higher Risk of Stroke and Death Compared to Men and Receive Less Attention
Even though the incidence of atrial fibrillation is higher in men than women, a review of past studies and medical literature completed by cardiac experts at Rush University Medical Center shows that women are more likely than men to experience symptomatic attacks, a higher frequency of recurrences, and significantly higher heart rates during atrial fibrillation, which increases the risk of stroke.
Mount Sinai first in nation to ablate atrial fibrillation using new visually-guided balloon catheter
Physicians at The Mount Sinai Medical Center in New York became the first in the U.S. to ablate atrial fibrillation using a visually-guided laser balloon catheter.
Atrial fibrillation: Drugs or ablation?
Atrial fibrillation ablation is one of the fastest growing techniques in cardiology and due to the very high number of patients that might be candidates to this procedure, a significant number of resources will have to be devoted to it to be able to treat them in the following years.
Irbesartan reduces heart failure in patients with quivering heart
Most research in atrial fibrillation (AF) has focused on reducing stroke and other embolic events. Yet heart failure occurs more frequently in AF patients, but has not been the focus of intervention research.
More Atrial Fibrillation Current Events and Atrial Fibrillation News Articles
 |
Atrial Fibrillation: From Bench to Bedside (Contemporary Cardiology) by Andrea Natale (Editor), José Jalife (Editor) Advancements in the treatment and prevention of Atrial Fibrillation are presented in this important new book. Atrial Fibrillation affects approximately 2.5 million individuals in the United States and is projected to affect 15 million individuals by 2050. In Atrial Fibrillation: From Bench to Bedside, the reader is provided with the latest information that is critically important in the daily care and for the potential cure of patients with Atrial Fibrillation. Each chapter deals with a different aspect of Atrial Fibrillation and was authored by internationally recognized experts in the evolving field of cardiac electrophysiology. This book is a single source that provides a multi-perspective look at and approach to Atrial Fibrillation. Because Atrial Fibrillation is so prevalent and... |
 |
Atrial Fibrillation Part of the award winning public television series Healthy Body/Healthy Mind. You know the signs...rapid heart beat... shortness of breath... panic! Sounds like a heart attack, or panic disorder. More often, it is Atrial Fibrillation, an irregular heartbeat disorder than can cause the heart to beat more than 300 times a minute. More than 2 million people have Atrial Fibrillation. Here's what happens: because of a problem with the electrical wiring in the heart, the two small upper chambers, the atria, quiver instead of beating effectively. This quivering causes the discomfort the patient feels, and can cause the blood to pool and clot. If a piece of blood clot leaves the heart and becomes lodged in an artery in the brain, a stroke results. About fifteen percent of strokes occur in people... |
 |
Atrial Fibrillation : My Heart, the Doctors, and Me by E. A. Butler (Author) An Investigative Report by an Inquisitive Patient The author felt compelled to write this story after discovering he had paroxysmal atrial fibrillation. He had little previous experience with personal illnesses. Now he found himself dealing with production line medicine. This experience fostered skepticism, doubts, apprehensions and grave concerns. He discovered he was afflicted with one of the most elusive and complex cardiovascular problems that involves the electrical impulse of the heart. This led him to unleash his investigative experience to find out why more hasn't been done to cure the malady. |
 |
Atrial Fibrillation (Fundamental and Clinical Cardiology) by Peter Kowey (Editor), Gerald Naccarelli (Editor) Filling a gap in the literature, this all-encompassing reference explores the epidemiology, mechanisms, and pathophysiology of atrial fibrillation and compiles the latest diagnostic and treatment practices for patient care. The book summarizes the most recent advances in symptom relief, drug development, device management, and long-term control of heart rhythm abnormalities and reviews the latest studies on the prevention of stroke and other thromboembolic events in patients with valvular and nonvalvular atrial fibrillation. Finally, it offers new strategies to improve the therapy and outcomes of patients suffering from the myriad of complications associated with atrial fibrillation. |
|
Atrial Fibrillation - The Most Common Arrhythmia (Have A Heart Series) Starring: Dr. Gerry Maddoux Directed By: Mark Baer Also With: Dr. Gerry Maddoux (Writer), Mark Baer (Producer) | |
 |
A Practical Approach To Catheter Ablation Of Atrial Fibrillation by Lippincott Williams & Wilkins A Practical Approach to Catheter Ablation of Atrial Fibrillation : A Practical Approach to Catheter Ablation of Atrial Fibrillation Pub Date: April 2008 Product Type: Print Author/s: Hugh Calkins MD; Pierre Jais MD; Jonathan S Steinberg MD Written and edited by expert electrophysiologists, this book is a practical, well-illustrated guide to the most successful techniques for catheter ablation of atrial fibrillation. While other texts address ablation of different arrhythmias, this is the first book to focus specifically on atrial fibrillation.Chapters explain how to establish programs and laboratories for treating atrial fibrillation; use complex imaging modalities and guidance systems; implement a variety of catheter-based ablation strategies, either isolated or in... |
 |
Atrial Fibrillation - The Most Common Arrhythmia (Have A Heart Series) Directed By: Mark Baer Also With: Mark Baer (Producer), Dr. Gerry Maddoux (Writer) * 2 Million people in America have atrial fibrillation. * Advancing age, high blood pressure and diabetes are common causes. * Embolic stroke (clot from the fibrillating left atrium) is the most common complication. This can be largely prevented with anticoagulation. * You can have a normal, healthy lifespan with atrial fibrillation. This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will apply. |
 |
A Practical Approach to Catheter Ablation of Atrial Fibrillation (Practical Approach (Lippincott & Wilkins)) by Hugh Calkins (Editor), Pierre Jais (Editor), Jonathan S Steinberg (Editor) Written and edited by expert electrophysiologists, this book is a practical, well-illustrated guide to the most successful techniques for catheter ablation of atrial fibrillation. While other texts address ablation of different arrhythmias, this is the first book to focus specifically on atrial fibrillation. Chapters explain how to establish programs and laboratories for treating atrial fibrillation; use complex imaging modalities and guidance systems; implement a variety of catheter-based ablation strategies, either isolated or in tandem; monitor the ablated patient's course for complications and arrhythmia recurrence; and manage these problems should they arise. The chapters on lab staffing and equipment, pre-procedure preparation, and post-procedure care will be of special interest to... |
 |
Critical Care Compendium by Mind-Forge Education Services LLC This is a collection of Self Learning Modules and pocket guides. Below are some of the modules and pocket guides in this product. **A quick handy guide to quickly interpret the 12 lead electrocardiogram, identify ischemia, reciprocal changes and to quickly localize a myocardial infarction and involved coronary arteries. **A brief presentation on atrial fibrillation/flutter, optimal monitoring leads, causes and complications related to open heart surgery. **A brief over view of current Advanced Cardiac Life Support treatment algorithms. **ACLS 2006 Code Drugs: Detailed description of 2006 ACLS code drugs and drip charts. (Current for 2007) **A detailed guide to the autonomic nervous system with emphasis placed on parasympathetic and sympathetic involvement and pharmacological... |
 |
Atrial Fibrillation, An Issue of Medical Clinics (The Clinics: Internal Medicine) by Ranjan K. Thakur (Author), Andrea Natale MD FACC FHRS (Author) Atrial fibrillation is the most common sustained arrhythmia in humans. An incredible worldwide effort from physicians, scientists and industry over the last decade has brought forth new insights and therapeutic tools. We are fortunate to have achieved a level of understanding about this complex disease that we can indeed cure some patients. While we proceed at full speed ahead looking for cures for the rest, we have taken this opportunity in the Medical Clinics of North America to reflect on how much we have learned and on the task that lies ahead. This issue opens with a historical perspective, discusses many of the clinical issues in the management of atrial fibrillation, such as cardioversion, anticoagulation and ablation, and concludes with the current guidelines for treatment and... |
| © 2009 BrightSurf.com |